An Early Phase I Study of IPdR Absorption, Metabolism, and Safety in Patients With Advanced Solid Tumors and Lymphomas
Clinical trial NCT01240577 · COMPLETED
Trial details
- NCT number
- NCT01240577
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-26
- Primary completion
- 2012-07-30
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.